Explore
Validate
Learn2697
antibody from Cell Signaling Technology, Inc
Targeting: CHUK
IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 2697 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#2697, RRID:AB_2079382
- Product name
- Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1.
Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes.
Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A.
Iwasaki H, Takeuchi O, Teraguchi S, Matsushita K, Uehata T, Kuniyoshi K, Satoh T, Saitoh T, Matsushita M, Standley DM, Akira S
Nature immunology 2011 Oct 30;12(12):1167-75
Nature immunology 2011 Oct 30;12(12):1167-75
Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes.
Kwong C, Gilman-Sachs A, Beaman K
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1781-9
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1781-9
Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A.
Barisic S, Schmidt C, Walczak H, Kulms D
Biochemical pharmacology 2010 Aug 15;80(4):439-47
Biochemical pharmacology 2010 Aug 15;80(4):439-47
No comments: Submit comment
No validations: Submit validation data